Power Law company profile

CF PharmTech

Biotech & Life Sciences · Suzhou Shi, China · Founded 2007 · IPO 2025 Colt

Specialty pharmaceutical company that develops and manufactures inhalation products

Valuation

$1.01B

Market cap · Apr/2026

Revenue

$84M

Latest reported FY

EBITDA

$10M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

14 investors on CF PharmTech's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 14 investors entered at this stage

ShenZhen GTJA Investment Group

Oriza Holdings

China Capital Investment Group

Cornerstone Capital

New Alliance Capital

Passion Capital

CR-CP Life Science Fund

BioTrack Capital

YuanMing Capital

Hengxu Capital

GT Capital

SAIC Capital

Xiangcheng Financial Holdings

SDIC Fund Management

Global footprint

Where CF PharmTech has talent and traffic

Workforce by country

🇨🇳 China · Suzhou Shi HQ

Book a demo for the full country breakdown

Web traffic by country

420 monthly visits
across markets

🇺🇸 United States95.2%

Top 1 markets shown

Market sentiment

What the market is saying about CF PharmTech

An AI-synthesized read of the highest-engagement posts about CF PharmTech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CF PharmTech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles